Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial von Hauschild, Axel, Prof, Grob, Jean-Jacques, Prof, Demidov, Lev V, Prof, Jouary, Thomas, MD, Gutzmer, Ralf, MD, Millward, Michael, MD, Rutkowski, Piotr, PhD, Blank, Christian U, PhD, Miller, Wilson H, PhD, Kaempgen, Eckhart, PhD, Martín-Algarra, Salvador, PhD, Karaszewska, Boguslawa, MD, Mauch, Cornelia, Prof, Chiarion-Sileni, Vanna, MD, Martin, Anne-Marie, PhD, Swann, Suzanne, PhD, Haney, Patricia, BSN, Mirakhur, Beloo, PhD, Guckert, Mary E, MSN, Goodman, Vicki, MD, Chapman, Paul B, MD

Volltext

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind st... von Long, Georgina V, Prof, Dummer, Reinhard, Prof, Hamid, Omid, MD, Gajewski, Thomas F, Prof, Caglevic, Christian, MD, Dalle, Stephane, Prof, Arance, Ana, MD, Carlino, Matteo S, PhD, Grob, Jean-Jacques, Prof, Kim, Tae Min, Prof, Demidov, Lev, Prof, Robert, Caroline, Prof, Larkin, James, Prof, Anderson, James R, PhD, Maleski, Janet, BSN, Jones, Mark, MD, Diede, Scott J, MD, Mitchell, Tara C, MD

Volltext

Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma von Larkin, James, Ascierto, Paolo A, Dréno, Brigitte, Atkinson, Victoria, Liszkay, Gabriella, Maio, Michele, Mandalà, Mario, Demidov, Lev, Stroyakovskiy, Daniil, Thomas, Luc, de la Cruz-Merino, Luis, Dutriaux, Caroline, Garbe, Claus, Sovak, Mika A, Chang, Ilsung, Choong, Nicholas, Hack, Stephen P, McArthur, Grant A, Ribas, Antoni

Volltext

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma von Flaherty, Keith T, Robert, Caroline, Hersey, Peter, Nathan, Paul, Garbe, Claus, Milhem, Mohammed, Demidov, Lev V, Hassel, Jessica C, Rutkowski, Piotr, Mohr, Peter, Dummer, Reinhard, Trefzer, Uwe, Larkin, James M.G, Utikal, Jochen, Dreno, Brigitte, Nyakas, Marta, Middleton, Mark R, Becker, Jürgen C, Casey, Michelle, Sherman, Laurie J, Wu, Frank S, Ouellet, Daniele, Martin, Anne-Marie, Patel, Kiran, Schadendorf, Dirk

Volltext

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial von Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Ascierto, Paolo A, MD, Arance, Ana, MD, Dutriaux, Caroline, MD, Di Giacomo, Anna Maria, MD, Rutkowski, Piotr, Prof, Del Vecchio, Michele, MD, Gutzmer, Ralf, Prof, Mandala, Mario, MD, Thomas, Luc, Prof, Demidov, Lev, Prof, Garbe, Claus, Prof, Hogg, David, MD, Liszkay, Gabriella, Prof, Queirolo, Paola, MD, Wasserman, Ernesto, MD, Ford, James, MS, Weill, Marine, MSc, Sirulnik, L Andres, MD, Jehl, Valentine, MSc, Bozón, Viviana, MD, Long, Georgina V, Prof, Flaherty, Keith, MD

Volltext

Pinpointing the tumor-specific T cells via TCR clusters von Goncharov, Mikhail M, Bryushkova, Ekaterina A, Sharaev, Nikita I, Skatova, Valeria D, Baryshnikova, Anastasiya M, Sharonov, George V, Karnaukhov, Vadim, Vakhitova, Maria T, Samoylenko, Igor V, Demidov, Lev V, Lukyanov, Sergey, Chudakov, Dmitriy M, Serebrovskaya, Ekaterina O

Volltext

Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials von Hauschild, Axel, Ascierto, Paolo A., Schadendorf, Dirk, Grob, Jean Jacques, Ribas, Antoni, Kiecker, Felix, Dutriaux, Caroline, Demidov, Lev V., Lebbé, Céleste, Rutkowski, Piotr, Blank, Christian U., Gutzmer, Ralf, Millward, Michael, Kefford, Richard, Haas, Tomas, D'Amelio, Anthony, Gasal, Eduard, Mookerjee, Bijoyesh, Chapman, Paul B.

Volltext

A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic... von Demidov, Lev, Kharkevich, Galina, Petenko, Natalia, Moiseenko, Vladimir, Protsenko, Svetlana, Semiglazova, Tatiana, Zimina, Anastasia, Kovalenko, Nadezhda, Fadeeva, Natalia, Kirtbaya, Dmitry, Belogortsev, Igor, Tantsyrev, Denis, Odintsova, Svetlana, Nesterova, Alfia, Vorontsova, Karina, Makarycheva, Yulia, Linkova, Yulia, Zinkina-Orikhan, Arina, Siliutina, Anna, Sorokina, Irina, Liaptseva, Daria, Chistyakov, Vladimir, Lutsky, Anton

Volltext

Melanoma arising in a Giant congenital melanocytic nevus: two case reports von Belysheva, Tatiana S, Vishnevskaya, Yana V, Nasedkina, Tatiana V, Emelyanova, Marina A, Abramov, Ivan S, Orlova, Kristina V, Lubchenko, Ludmila N, Utyashev, Igor A, Doroshenko, Marina B, Demidov, Lev V, Aliev, Mamed D

Volltext

Detection of mutations in the BRAF in patients with melanoma in routine clinical practice: Survey results von Orlova, Kristina V., Demidov, Lev V.

Volltext

Triple combination of vemurafenib, cobimetinib, and atezolizumab in real clinical practice in the Russian Federation: results of the A1 cohort of the ISABELLA study von Samoylenko, Igor V, Kolontareva, Yulia M, Kogay, Ekaterina V, Zhukova, Natalia V, Utyashev, Igor A, Ivannikov, Mikhail E, Menshikov, Konstantin V, Zinkevich, Maxim V, Orlova, Kristina V, Vakhabova, Yulia V, Volkonsky, Mikhail V, Beliaeva, Natalia A, Butkov, Ivan I, Karabina, Elena V, Moskovkina, Tatyana L, Moshkova, Kseniya A, Plishkina, Olga V, Sychev, Vitaliy D, Cheplukhova, Oxana S, Chernova, Vera V, Yurchenkov, Alexandr N, Babina, Ksenia G, Savelov, Nikita A, Demidov, Lev V

Volltext

Bone Marrow Involvement in Melanoma. Potentials for Detection of Disseminated Tumor Cells and Characterization of Their Subsets by Flow Cytometry von Chernysheva, Olga, Markina, Irina, Demidov, Lev, Kupryshina, Natalia, Chulkova, Svetlana, Palladina, Alexandra, Antipova, Alina, Tupitsyn, Nikolai

Volltext

Real-World Experience with Targeted Therapy in BRAF Mutant Advanced Melanoma Patients: Results from a Multicenter Retrospective Observational Study Advanced Melanoma in Russia (Exp... von Orlova, Kristina V., Ledin, Evgeniy V., Zhukova, Natalia V., Orlova, Rashida V., Karabina, Elena V., Volkonskiy, Mikhail V., Stroyakovskiy, Daniil L., Yurchenkov, Aleksandr N., Protsenko, Svetlana A., Novik, Alexey V., Vorotilina, Ludmila V., Moiseenko, Fedor V., Chang, Victor L., Kazmin, Aleksandr I., Tkachenko, Svetlana A., Gamaunov, Sergey V., Naskhletashvili, David R., Samoylenko, Igor V., Vikhrova, Anastasia S., Utyashev, Igor A., Kharkevich, Galina Yu, Petenko, Natalia N., Shubina, Irina Zh, Demidov, Lev V.

Volltext

Screening for Melanoma and Other Skin Cancer Shows a Higher Early Melanoma Incidence: Social Educational Program "Life Fear-Free" von Demidov, Lev, Samoylenko, Igor, Vand, Nina, Utyashev, Igor, Shubina, Irina, Sinelnikov, Igor

Volltext

Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma von Tsimafeyeu, Ilya V, Demidov, Lev V, Madzhuga, Albina V, Somonova, Oksana V, Yelizarova, Anna L

Volltext

Combination of encorafenib and binimetinib in the treatment of patients with BRAF-mutated advanced melanoma. Case report von Orlova, Kristina V., Petenko, Natalia N., Garanina, Natalia V., Demidov, Lev V.

Volltext

Lack of Response to Imatinib in Melanoma Carrying Rare KIT Mutation р.T632I von Orlova, Kristina V., Yanus, Grigory A., Aleksakhina, Svetlana N., Venina, Aigul R., Iyevleva, Aglaya G., Demidov, Lev V., Imyanitov, Evgeny N.

Volltext

432 3-year results of the phase 2 randomized trial for talimogene laherparepvec (T-VEC) neoadjuvant treatment plus surgery vs surgery in patients with resectable stage IIIB-IVM1a m... von Dummer, Reinhard, Gyorki, David, Hyngstrom, John, Berger, Adam, Conry, Robert, Demidov, Lev, Chan, Edward, Radcliffe, Hoi-Shen, Faries, Mark, Ross, Merrick

Volltext

Immunological monitoring for prediction of clinical response to antitumor vaccine therapy von Mikhaylova, Irina N, Shubina, Irina Zh, Chkadua, George Z, Petenko, Natalia N, Morozova, Lidia F, Burova, Olga S, Beabelashvili, Robert Sh, Parsunkova, Kermen A, Balatskaya, Natalia V, Chebanov, Dmitrii K, Pospelov, Vadim I, Nazarova, Valeria V, Vihrova, Anastasia S, Cheremushkin, Evgeny A, Molodyk, Alvina A, Kiselevsky, Mikhail V, Demidov, Lev V

Volltext

Cobimetinib combined with vemurafenib in advanced BRAFV600 -mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial von Ascierto, Paolo A, MD, McArthur, Grant A, Prof, Dréno, Brigitte, Prof, Atkinson, Victoria, MD, Liszkay, Gabrielle, MD, Di Giacomo, Anna Maria, MD, Mandalà, Mario, MD, Demidov, Lev, MD, Stroyakovskiy, Daniil, MD, Thomas, Luc, Prof, de la Cruz-Merino, Luis, MD, Dutriaux, Caroline, MD, Garbe, Claus, Prof, Yan, Yibing, PhD, Wongchenko, Matthew, BS, Chang, Ilsung, PhD, Hsu, Jessie J, PhD, Koralek, Daniel O, PhD, Rooney, Isabelle, MBChB, Ribas, Antoni, Prof, Larkin, James, FRCP

Volltext